10 insiders reported 56 Form 4 transactions for Processa Pharmaceuticals, Inc. (PCSA) over the past 18 months (most recent 2026-07-01). Recent activity: SKIBSTED RUSSELL (Chief Financial Officer) Buy 3,277 shares, Young David (Pres. Research & Development) Buy 2,531 shares, Ng George K (Chief Executive Officer) Buy 3,057 shares, Guy Wendy (Chief Administrative Officer) Buy 2,436 shares, Lin Patrick (Chief Business - Strategy Off) Buy 2,106 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | SKIBSTED RUSSELL | Chief Financial Officer | Buy | 3,277 | $6,325 |
| 2026-07-01 | Young David | Pres. Research & Development | Buy | 2,531 | $4,885 |
| 2026-07-01 | Ng George K | Chief Executive Officer | Buy | 3,057 | $5,900 |
| 2026-07-01 | Guy Wendy | Chief Administrative Officer | Buy | 2,436 | $4,701 |
| 2026-07-01 | Lin Patrick | Chief Business - Strategy Off | Buy | 2,106 | $4,065 |
| 2026-06-30 | Yorke Justin W | Director | Buy | 203 | $0 |
| 2026-06-30 | Neal James R | Director | Buy | 203 | $0 |
| 2026-06-30 | Baluch Khoso | Director | Buy | 203 | $0 |
| 2026-06-30 | Pannu Geraldine | Director | Buy | 203 | $0 |
| 2026-06-16 | Ng George K | Chief Executive Officer | Buy | 2,465 | $5,472 |
| 2026-06-16 | SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,654 | $5,892 |
| 2026-06-16 | Young David | Pres. Research & Development | Buy | 2,067 | $4,589 |
| 2026-06-16 | Guy Wendy | Chief Administrative Officer | Buy | 2,118 | $4,702 |
| 2026-06-16 | Lin Patrick | Chief Business - Strategy Off | Buy | 1,831 | $4,065 |
| 2026-06-01 | Young David | Pres. Research & Development | Buy | 1,786 | $4,590 |
| 2026-06-01 | Ng George K | Chief Executive Officer | Buy | 2,129 | $5,472 |
| 2026-06-01 | Guy Wendy | Chief Administrative Officer | Buy | 1,829 | $4,701 |
| 2026-06-01 | Lin Patrick | Chief Business - Strategy Off | Buy | 1,582 | $4,066 |
| 2026-06-01 | SKIBSTED RUSSELL | Chief Financial Officer | Buy | 2,292 | $5,890 |
| 2026-05-19 | SKIBSTED RUSSELL | Chief Financial Officer | Buy | 1,984 | $5,892 |
| 2026-05-19 | Young David | Pres. Research & Development | Buy | 1,545 | $4,589 |
| 2026-05-19 | Ng George K | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2026-05-19 | Ng George K | Chief Executive Officer | Buy | 1,843 | $5,474 |
| 2026-05-19 | Guy Wendy | Chief Administrative Officer | Buy | 1,583 | $4,702 |
| 2026-05-19 | Lin Patrick | Chief Business - Strategy Off | Buy | 1,369 | $4,066 |
Source: SEC Form 4 filings · as of 2026-07-01